In the last trading session, 0.53 million shares of the CERo Therapeutics Holdings Inc (NASDAQ:CERO) were traded, and its beta was 0.68. Most recently the company’s share price was $0.79, and it changed around -$0.06 or -7.21% from the last close, which brings the market valuation of the company to $4.41M. CERO currently trades at a discount to its 52-week high of $143.00, offering almost -18001.27% off that amount. The share price’s 52-week low was $0.53, which indicates that the current value has risen by an impressive 32.91% since then.
CERo Therapeutics Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended CERO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. CERo Therapeutics Holdings Inc is expected to report earnings per share of -5.96 for the current quarter.
CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information
Instantly CERO has showed a red trend with a performance of -7.21% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9896 on recent trading dayincreased the stock’s daily price by 20.17%. The company’s shares are currently down -86.83% year-to-date, but still down -14.59% over the last five days. On the other hand, CERo Therapeutics Holdings Inc (NASDAQ:CERO) is 13.02% up in the 30-day period.
CERo Therapeutics Holdings Inc earnings are expected to increase by 59.83% in 2025, but the outlook is positive 62.86% per year for the next five years.
CERO Dividends
CERo Therapeutics Holdings Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 4.92 shares worth $3890.0, making up 0.09% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 1.12 shares worth around $884.0, which represents about 0.02% of the total shares outstanding.
